The guests on the show put it plainly.

You need money to build regulated medical hardware.

So can we raise money for it? So the first sort of 12, 18 months of Bayer, sort of 2020 into early 21, was a lot of grappling with feasibility, building docs, trying to pitch, trying to figure it out.

And eating a lot of beans because, of course, you're not taking a check at that point because there's no monies.

Of course, it's probably going to come as no surprise that to close my very first round of funding, I ended up speaking to something like 283 investors.

And I think I closed 15 of them.

And, you know, of course, like I was pretty naive at the time.

I was like,